Insider Buying: Diagnos Inc (CVE:ADK) Director Buys 75,351 Shares of Stock

Diagnos Inc (CVE:ADK) Director André Larente bought 75,351 shares of Diagnos stock in a transaction dated Wednesday, December 4th. The shares were acquired at an average price of C$0.16 per share, with a total value of C$12,056.16. Following the completion of the purchase, the director now directly owns 185,984 shares in the company, valued at approximately C$29,757.44.

Shares of CVE ADK traded up C$0.02 during midday trading on Wednesday, hitting C$0.16. 165,165 shares of the company’s stock were exchanged, compared to its average volume of 67,816. Diagnos Inc has a 12 month low of C$0.10 and a 12 month high of C$0.50. The company’s 50 day moving average price is C$0.14 and its 200 day moving average price is C$0.23. The firm has a market capitalization of $6.19 million and a PE ratio of -0.91.

About Diagnos

DIAGNOS Inc provides software-based interpretation services primarily in Canada, the United Arab Emirates, Saudi Arabia, Slovakia, and the United States. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy.

Featured Article: What is a blue-chip stock?

Receive News & Ratings for Diagnos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diagnos and related companies with MarketBeat.com's FREE daily email newsletter.